tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PYC Therapeutics Unveils Promising Trial Results for Retinitis Pigmentosa Treatment
Company AnnouncementsPYC Therapeutics Unveils Promising Trial Results for Retinitis Pigmentosa Treatment
2d ago
PYC
PYC Therapeutics Announces Change in Substantial Shareholder Interests
PremiumCompany Announcements
PYC Therapeutics Announces Change in Substantial Shareholder Interests
6d ago
PYC
PYC Therapeutics Reports Positive Clinical Trial Results for Eye Disease Treatment
PremiumCompany Announcements
PYC Therapeutics Reports Positive Clinical Trial Results for Eye Disease Treatment
6d ago
PYC
PYC Therapeutics Advances Towards Commercial Stage with Extended Funding
PremiumCompany Announcements
PYC Therapeutics Advances Towards Commercial Stage with Extended Funding
10d ago
PYC
PYC Therapeutics Announces Quotation of New Securities on ASX
PremiumCompany Announcements
PYC Therapeutics Announces Quotation of New Securities on ASX
11d ago
PYC
PYC Therapeutics Secures $146 Million in Entitlement Offer to Advance RNA Therapies
PremiumCompany AnnouncementsPYC Therapeutics Secures $146 Million in Entitlement Offer to Advance RNA Therapies
17d ago
PYC
PYC Therapeutics Advances PYC-003 in Polycystic Kidney Disease Trial
Premium
Company Announcements
PYC Therapeutics Advances PYC-003 in Polycystic Kidney Disease Trial
24d ago
PYC
PYC Therapeutics Secures Majority of Entitlement Offer Amid Underwriter Delays
Premium
Company Announcements
PYC Therapeutics Secures Majority of Entitlement Offer Amid Underwriter Delays
25d ago
PYC
PYC Therapeutics Updates Investors on Business Progress
PremiumCompany Announcements
PYC Therapeutics Updates Investors on Business Progress
1M ago
PYC
Buy Rating for PYC Therapeutics: Promising Pipeline and Market Position in Genetic Medicine
PremiumRatings
Buy Rating for PYC Therapeutics: Promising Pipeline and Market Position in Genetic Medicine
1M ago
PYC Therapeutics Completes Retail Entitlement Offer, Raising $9.3 Million
PremiumCompany Announcements
PYC Therapeutics Completes Retail Entitlement Offer, Raising $9.3 Million
2M ago
PYC
PYC Therapeutics Releases Interim Financial Statements and Reinforces Commitment to RNA Therapies
PremiumCompany Announcements
PYC Therapeutics Releases Interim Financial Statements and Reinforces Commitment to RNA Therapies
2M ago
PYC
PYC Therapeutics Expands Market Presence with New Securities Quotation
PremiumCompany AnnouncementsPYC Therapeutics Expands Market Presence with New Securities Quotation
2M ago
PYC
PYC Therapeutics Launches $146 Million Entitlement Offer
Premium
Company Announcements
PYC Therapeutics Launches $146 Million Entitlement Offer
2M ago
PYC
PYC Therapeutics Launches Retail Entitlement Offer to Fund RNA Therapy Development
Premium
Company Announcements
PYC Therapeutics Launches Retail Entitlement Offer to Fund RNA Therapy Development
2M ago
PYC
PYC Therapeutics Announces Retail Entitlement Offer
PremiumCompany Announcements
PYC Therapeutics Announces Retail Entitlement Offer
2M ago
PYC
PYC Therapeutics Secures $146 Million to Advance Drug Pipeline
PremiumCompany Announcements
PYC Therapeutics Secures $146 Million to Advance Drug Pipeline
2M ago
PYC
PYC Therapeutics Launches A$145.8 Million Entitlement Offer
PremiumCompany Announcements
PYC Therapeutics Launches A$145.8 Million Entitlement Offer
3M ago
PYC
PYC Therapeutics to Issue 116.6 Million Securities in Accelerated Offer
PremiumCompany Announcements
PYC Therapeutics to Issue 116.6 Million Securities in Accelerated Offer
3M ago
PYC
PYC Therapeutics Launches Equity Raising to Bolster Financial Position
PremiumCompany AnnouncementsPYC Therapeutics Launches Equity Raising to Bolster Financial Position
3M ago
PYC
PYC Therapeutics to Raise $146 Million for Drug Pipeline Advancement
Premium
Company Announcements
PYC Therapeutics to Raise $146 Million for Drug Pipeline Advancement
3M ago
PYC
PYC Therapeutics Announces Trading Halt Pending Capital Raising
Premium
Company Announcements
PYC Therapeutics Announces Trading Halt Pending Capital Raising
3M ago
PYC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >